Hetrombopag Prevents Cancer Therapy-Induced Thrombocytopenia in Breast Cancer: Randomized Phase II Trial
Cancer therapy-induced thrombocytopenia, a potentially treatment-limiting fall in platelet numbers, is drawing renewed attention after a multicenter phase II trial ...
